Vicarious Surgical (RBOTW) Cash from Investing Activities (2020 - 2025)
Vicarious Surgical (RBOTW) reported Cash from Investing Activities of $9.7 million for Q3 2025, up 2069.92% year-over-year from $446652.7 in Q3 2024, and down 34.6% quarter-over-quarter from $14.8 million in Q2 2025.
Vicarious Surgical (RBOTW) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Cash from Investing Activities data on file, last reported at $9.7 million in Q3 2025.
- Cash from Investing Activities for Q3 2025 came in at $9.7 million, up 2069.92% year-over-year; the trailing twelve-month figure through Sep 2025 was $43.6 million (up 1814.16% YoY), and the FY2024 annual result was $6.9 million, up 114.99% from the prior year.
- Cash from Investing Activities fell to $9.7 million in Q3 2025 per RBOTW's latest filing, from $14.8 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $14.8 million in Q2 2025 and troughed at -$43.8 million in Q1 2023.
- A 5-year average of -$865105.3 and a median of -$492000.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities tumbled 2067.56% in 2023, then soared 3303.47% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$867000.0 in 2021, then fell by 14.42% to -$992000.0 in 2022, then surged by 608.57% to $5.0 million in 2023, then surged by 186.42% to $14.4 million in 2024, then tumbled by 32.93% to $9.7 million in 2025.
- Business Quant data shows RBOTW's Cash from Investing Activities at $9.7 million in Q3 2025, $14.8 million in Q2 2025, and $4.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.69 Mn |
| Sep 30, 2025 | 9.69 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | -6.95 Mn |
| Jun 30, 2024 | -6.95 Mn |
| Mar 31, 2024 | -144,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Dec 31, 2023 | 5.05 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | -644,000.00 |
| Sep 30, 2023 | -644,000.00 |
| Jun 30, 2023 | -6.36 Mn |
| Jun 30, 2023 | -6.36 Mn |